Okrelizumab (Q58345): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Updating statements of entity ["Okrelizumab" (pl), "Okrelizumab" (en)] with Lapacz) |
(Changed an Item: Updating statements of entity ["Okrelizumab" (pl)] with Lapacz) |
||
Property / Type | |||
Property / Type: Unknown / rank | |||
Property / Version | |||
Property / Version: Francesca Findabair / rank | |||
Property / National Library Identifier | |||
a0000003825403 | |||
Property / National Library Identifier: a0000003825403 / rank | |||
Normal rank | |||
Property / Related Subject | |||
Property / Related Subject: Stwardnienie rozsiane / rank | |||
Normal rank | |||
Property / Type | |||
Property / Type: Unknown / rank | |||
Normal rank | |||
Property / Version | |||
P11015T34968 | |||
Property / Version: P11015T34968 / rank | |||
Normal rank |
Latest revision as of 03:25, 25 November 2023
No description defined
Language | Label | Description | Also known as |
---|---|---|---|
English | Okrelizumab |
No description defined |
Statements
a0000003825403
0 references
P11015T34968
0 references